Skip to main content

Table 5 Cases vs controls as regards miRNA cluster. All members of the cluster were overexpressed in the patient group than the control group

From: Prognostic significance of microRNA 17–92 cluster expression in Egyptian chronic lymphocytic leukemia patients

Parameter

CLL cases (n = 40)

Controls (n = 20)

Test of significance (p value)

MiR17

Min.–max

1.11–41.01

0.4–2.05

Z =  − 5.9 (p < 0.001)

Mean ± SD

9.16 ± 10.67

1.1 ± 0.5

Median

4.22

1.06

MiR18a

Min.–max

1.31–30.78

0.54–2.16

Z =  − 6 (p < 0.001)

Mean ± SD

9.07 ± 7.37

1.1 ± 0.56

Median

6.8

0.94

MiR19a

Min.–max

0.09–1189.38

0.55–1.87

Z =  − 4.4 (p < 0.001)

Mean ± SD

89.36 ± 216.41

1.09 ± 0.47

Median

9.11

0.98

MiR19b-1

Min.–max

0.02–122.96

0.49–1.5

Z =  − 2.5 (p = 0.01)

Mean ± SD

17.48 ± 27.87

1.07 ± 0.35

Median

8.42

1.13

MiR20a

Min.–max

2.33–53.89

0.62–1.6

Z =  − 6.3 (p < 0.001)

Mean ± SD

10.86 ± 10.82

1.05 ± 0.34

Median

7.25

1.04

MiR92a-1

Min.–max

0.55–42.75

0.65—1.4

Z =  − 5.3 (p < 0.001)

Mean ± SD

6.78 ± 7.93

1.03 ± 0.26

Median

4.36

0.98

  1. Z Mann–Whitney test; significant (p ≤ 0.05)